Search

Your search keyword '"Edwards, Joanne"' showing total 950 results
Start Over Author "Edwards, Joanne"
950 results on '"Edwards, Joanne"'

2. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

Author

Pennel, Kathryn A. F., Hatthakarnkul, Phimmada, Wood, Colin S., Lian, Guang-Yu, Al-Badran, Sara S. F., Quinn, Jean A., Legrini, Assya, Inthagard, Jitwadee, Alexander, Peter G., van Wyk, Hester, Kurniawan, Ahmad, Hashmi, Umar, Gillespie, Michael A., Mills, Megan, Ammar, Aula, Hay, Jennifer, Andersen, Ditte, Nixon, Colin, Rebus, Selma, Chang, David K., Kelly, Caroline, Harkin, Andrea, Graham, Janet, Church, David, Tomlinson, Ian, Saunders, Mark, Iveson, Tim, Lannagan, Tamsin R. M., Jackstadt, Rene, Maka, Noori, Horgan, Paul G., Roxburgh, Campbell S. D., Sansom, Owen J., McMillan, Donald C., Steele, Colin W., Jamieson, Nigel B., Park, James H., Roseweir, Antonia K., and Edwards, Joanne

Published
2024
Full Text
View/download PDF

3. Corrigendum

Author

Beach, Callum, MacLean, David, Majorova, Dominika, Melemenidis, Stavros, Nambiar, Dhanya K., Kim, Ryan K., Valbuena, Gabriel N., Guglietta, Silvia, Krieg, Carsten, Darvish-Damavandi, Mahnaz, Suwa, Tatsuya, Easton, Alistair, Hillson, Lily V.S., McCulloch, Ashley K., McMahon, Ross K., Pennel, Kathryn, Edwards, Joanne, O'Cathail, Sean M., Roxburgh, Campbell S., Domingo, Enric, Moon, Eui Jung, Jiang, Dadi, Jiang, Yanyan, Zhang, Qingyang, Koong, Albert C., Woodruff, Trent M., Graves, Edward E., Maughan, Tim, Buczacki, Simon J.A., Stucki, Manuel, Le, Quynh-Thu, Leedham, Simon J., Giaccia, Amato J., and Olcina, Monica M.

Abstract

Original citation: J Clin Invest. 2023;133(23):e168277. https://doi.org/10.n72/JCI168277. During the preparation of this manuscript, the dose for PMX205 used for in vitro experiments was stated incorrectly in the legend for Figure [...]

Published
2024
Full Text
View/download PDF

4. Ensuring accurate stain reproduction in deep generative networks for virtual immunohistochemistry

Author

Walsh, Christopher D., Edwards, Joanne, and Insall, Robert H.

Subjects
Electrical Engineering and Systems Science - Image and Video Processing, Computer Science - Computer Vision and Pattern Recognition, Quantitative Biology - Quantitative Methods, I.4.3, I.4.5
Abstract

Immunohistochemistry is a valuable diagnostic tool for cancer pathology. However, it requires specialist labs and equipment, is time-intensive, and is difficult to reproduce. Consequently, a long term aim is to provide a digital method of recreating physical immunohistochemical stains. Generative Adversarial Networks have become exceedingly advanced at mapping one image type to another and have shown promise at inferring immunostains from haematoxylin and eosin. However, they have a substantial weakness when used with pathology images as they can fabricate structures that are not present in the original data. CycleGANs can mitigate invented tissue structures in pathology image mapping but have a related disposition to generate areas of inaccurate staining. In this paper, we describe a modification to the loss function of a CycleGAN to improve its mapping ability for pathology images by enforcing realistic stain replication while retaining tissue structure. Our approach improves upon others by considering structure and staining during model training. We evaluated our network using the Fr\'echet Inception distance, coupled with a new technique that we propose to appraise the accuracy of virtual immunohistochemistry. This assesses the overlap between each stain component in the inferred and ground truth images through colour deconvolution, thresholding and the Sorensen-Dice coefficient. Our modified loss function resulted in a Dice coefficient for the virtual stain of 0.78 compared with the real AE1/AE3 slide. This was superior to the unaltered CycleGAN's score of 0.74. Additionally, our loss function improved the Fr\'echet Inception distance for the reconstruction to 74.54 from 76.47. We, therefore, describe an advance in virtual restaining that can extend to other immunostains and tumour types and deliver reproducible, fast and readily accessible immunohistochemistry worldwide., Comment: Eighteen pages, six figures

Published
2022

6. Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer

Author

Glimelius, Bengt, Gogenur, Ismail, Jaeger, Emma, Morgan, Hannah, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Nowak, Marta, Jabbar, Faiz, Rodewald, Ann-Katrin, Gneo, Luciana, Tomasevic, Tijana, Harkin, Andrea, Iveson, Tim, Saunders, Mark, Kerr, Rachel, Oein, Karin, Maka, Noori, Hay, Jennifer, Edwards, Joanne, Tomlinson, Ian, Sansom, Owen, Kelly, Caroline, Pezzella, Francesco, Kerr, David, Easton, Alistair, Domingo, Enric, Koelzer, Viktor H., and Church, David N.

Published
2024
Full Text
View/download PDF

7. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

Author

Vande Voorde, Johan, Steven, Rory T., Najumudeen, Arafath K., Ford, Catriona A., Dexter, Alex, Gonzalez-Fernandez, Ariadna, Nikula, Chelsea J., Xiang, Yuchen, Ford, Lauren, Maneta Stavrakaki, Stefania, Gilroy, Kathryn, Zeiger, Lucas B., Pennel, Kathryn, Hatthakarnkul, Phimmada, Elia, Efstathios A., Nasif, Ammar, Murta, Teresa, Manoli, Eftychios, Mason, Sam, Gillespie, Michael, Lannagan, Tamsin R. M., Vlahov, Nikola, Ridgway, Rachel A., Nixon, Colin, Raven, Alexander, Mills, Megan, Athineos, Dimitris, Kanellos, Georgios, Nourse, Craig, Gay, David M., Hughes, Mark, Burton, Amy, Yan, Bin, Sellers, Katherine, Wu, Vincen, De Ridder, Kobe, Shokry, Engy, Huerta Uribe, Alejandro, Clark, William, Clark, Graeme, Kirschner, Kristina, Thienpont, Bernard, Li, Vivian S. W., Maddocks, Oliver D. K., Barry, Simon T., Goodwin, Richard J. A., Kinross, James, Edwards, Joanne, Yuneva, Mariia O., Sumpton, David, Takats, Zoltan, Campbell, Andrew D., Bunch, Josephine, and Sansom, Owen J.

Published
2023
Full Text
View/download PDF

11. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis

Author

Church, David N, Domingo, Enric, Edwards, Joanne, Glimelius, Bengt, Gonegur, Ismail, Harkin, Andrea, Hay, Jen, Iveson, Timothy, Jaeger, Emma, Kelly, Caroline, Kerr, Rachel, Maka, Noori, Morgan, Hannah, Oien, Karen, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Sansom, Owen, Saunders, Mark P, Tomlinson, Ian, Frei, Anja L, McGuigan, Anthony, Sinha, Ritik R A K, Jabbar, Faiz, Gneo, Luciana, Tomasevic, Tijana, Iveson, Tim, Oien, Karin A, Pezzella, Francesco, Campo, Leticia, Browne, Molly, Glaire, Mark, Kildal, Wanja, Danielsen, Havard E, Hay, Jennifer, Kerr, David, and Koelzer, Viktor H

Published
2024
Full Text
View/download PDF

13. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

Author

Beach, Callum, MacLean, David, Majorova, Dominika, Melemenidis, Stavros, Nambiar, Dhanya K., Kim, Ryan K., Valbuena, Gabriel N., Guglietta, Silvia, Krieg, Carsten, Darvish-Damavandi, Mahnaz, Suwa, Tatsuya, Easton, Alistair, Hillson, Lily V.S., McCulloch, Ashley K., McMahon, Ross K., Pennel, Kathryn, Edwards, Joanne, O'Cathail, Sean M., Roxburgh, Campbell S., Domingo, Enric, Moon, Eui Jung, Jiang, Dadi, Jiang, Yanyan, Zhang, Qingyang, Koong, Albert C., Woodruff, Trent M., Graves, Edward E., Maughan, Tim, Buczacki, Simon J.A., Stucki, Manuel, Le, Quynh-Thu, Leedham, Simon J., Giaccia, Amato J., and Olcina, Monica M.

Subjects
Thermo Fisher Scientific Inc., Scientific equipment and supplies industry, Gene expression, T cells, Tumors, Genes, Cancer -- Diagnosis, Colorectal cancer, Ethylenediaminetetraacetic acid, B cells, Radiotherapy, Health care industry, Wellcome Trust
Abstract

An immunosuppressive microenvironment causes poor tumor T cell infiltration and is associated with reduced patient overall survival in colorectal cancer. How to improve treatment responses in these tumors is still a challenge. Using an integrated screening approach to identify cancer-specific vulnerabilities, we identified complement receptor C5aR1 as a druggable target, which when inhibited improved radiotherapy, even in tumors displaying immunosuppressive features and poor [CD8.sup.+] T cell infiltration. While C5aR1 is well-known for its role in the immune compartment, we found that C5aR1 is also robustly expressed on malignant epithelial cells, highlighting potential tumor cell-specific functions. C5aR1 targeting resulted in increased NF-[kappa]B-dependent apoptosis specifically in tumors and not normal tissues, indicating that, in malignant cells, C5aR1 primarily regulated cell fate. Collectively, these data revealed that increased complement gene expression is part of the stress response mounted by irradiated tumors and that targeting C5aR1 could improve radiotherapy, even in tumors displaying immunosuppressive features., Introduction The composition of the tumor microenvironment (TME) affects treatment responses in cancer (1-3). Immunosuppressive TME features, which act as a barrier to extensive [CD8.sup.+] T cell infiltration typically characterize [...]

Published
2023
Full Text
View/download PDF

14. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

Author

Church, David, Domingo, Enric, Edwards, Joanne, Glimelius, Bengt, Gogenur, Ismail, Harkin, Andrea, Hay, Jen, Iveson, Timothy, Jaeger, Emma, Kelly, Caroline, Kerr, Rachel, Maka, Noori, Morgan, Hannah, Oien, Karin, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Sansom, Owen, Saunders, Mark, Tomlinson, Ian, Wagner, Sophia J., Reisenbüchler, Daniel, West, Nicholas P., Niehues, Jan Moritz, Zhu, Jiefu, Foersch, Sebastian, Veldhuizen, Gregory Patrick, Quirke, Philip, Grabsch, Heike I., van den Brandt, Piet A., Hutchins, Gordon G.A., Richman, Susan D., Yuan, Tanwei, Langer, Rupert, Jenniskens, Josien C.A., Offermans, Kelly, Mueller, Wolfram, Gray, Richard, Gruber, Stephen B., Greenson, Joel K., Rennert, Gad, Bonner, Joseph D., Schmolze, Daniel, Jonnagaddala, Jitendra, Hawkins, Nicholas J., Ward, Robyn L., Morton, Dion, Seymour, Matthew, Magill, Laura, Nowak, Marta, Hay, Jennifer, Koelzer, Viktor H., Church, David N., Matek, Christian, Geppert, Carol, Peng, Chaolong, Zhi, Cheng, Ouyang, Xiaoming, James, Jacqueline A., Loughrey, Maurice B., Salto-Tellez, Manuel, Brenner, Hermann, Hoffmeister, Michael, Truhn, Daniel, Schnabel, Julia A., Boxberg, Melanie, Peng, Tingying, and Kather, Jakob Nikolas

Published
2023
Full Text
View/download PDF

20. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer

Author

Hatthakarnkul, Phimmada, primary, Pennel, Kathryn, additional, Alexander, Peter, additional, van Wyk, Hester, additional, Roseweir, Antonia, additional, Inthagard, Jitwadee, additional, Hay, Jennifer, additional, Andersen, Ditte, additional, Maka, Noori, additional, Park, James, additional, Roxburgh, Campbell, additional, Thuwajit, Chanitra, additional, McMillan, Donald, additional, and Edwards, Joanne, additional

Published
2024
Full Text
View/download PDF

24. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer

Author

Lampis, Andrea, Hahne, Jens C., Gasparini, Pierluigi, Cascione, Luciano, Hedayat, Somaieh, Vlachogiannis, Georgios, Murgia, Claudio, Fontana, Elisa, Edwards, Joanne, Horgan, Paul G., Terracciano, Luigi, Sansom, Owen J., Martins, Carlos D., Kramer-Marek, Gabriela, Croce, Carlo M., Braconi, Chiara, Fassan, Matteo, and Valeri, Nicola

Published
2021
Full Text
View/download PDF

28. The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer

Author

Alexander, Peter G., Roseweir, Antonia K., Pennel, Kathryn A. F., van Wyk, Hester C., Powell, Arfon G. M. T., McMillan, Donald C., Horgan, Paul G., Kelly, Caroline, Hay, Jennifer, Sansom, Owen, Harkin, Andrea, Roxburgh, Campbell S. D., Graham, Janet, Church, David N., Tomlinson, Ian, Saunders, Mark, Iveson, Tim J., Edwards, Joanne, and Park, James H.

Published
2021
Full Text
View/download PDF

29. The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients.

Author

Jirapongwattana, Niphat, Thongchot, Suyanee, Pongpaibul, Ananya, Trakarnsanga, Atthaphorn, Quinn, Jean, Thuwajit, Peti, Thuwajit, Chanitra, and Edwards, Joanne

Subjects
COLORECTAL cancer, PERIOSTIN, SNAILS, CANCER patients, CANCER-related mortality, PROGRESSION-free survival
Abstract

Colorectal cancer (CRC) is the third most common malignancy cause of cancer-related mortality worldwide. Epithelial-mesenchymal transition (EMT) promotes cancer metastasis and a tumour-based Glasgow EMT score was associated with adverse clinical features and poor prognosis. In this study, the impact of using the established five tumour-based EMT markers consisting of E-cadherin (E-cad), β-catenin (β-cat), Snail, Zeb-1, and Fascin in combination with the stromal periostin (PN) on the prediction of CRC patients' prognosis were invesigated. Formalin-fixed paraffin-embedded tissues of 202 CRC patients were studies the expressions of E-cad, β-cat, Snail, Zeb-1, Fascin, and PN by immunohistochemistry. Individually, cytoplasmic Fascin (Fc), cytoplasmic Snail (Sc), nuclear Snail (Sn), stromal Snail (Ss), and stromal PN (Ps) were significantly associated with reduced survival. A combination of Ps with Fc, Fs, and Sn was observed in 2 patterns including combined Fc, Fs, and Ps (FcFsPs) and Fc, Sn, and Ps (FcSnPs). These combinations enhanced the prognostic power compared to individual EMT markers and were independent prognostic markers. As the previously established scoring method required five markers and stringent criteria, its clinical use might be limited. Therefore, using these novel combined prognostic markers, either FcFsPs or FcSnPs, may be useful in predicting CRC patient outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.

Author

Domingo, Enric, Kelly, Caroline, Hay, Jennifer, Sansom, Owen, Maka, Noori, Oien, Karin, Iveson, Tim, Saunders, Mark, Kerr, Rachel, Tomlinson, Ian, Edwards, Joanne, Harkin, Andrea, Nowak, Marta, Koelzer, Viktor, Easton, Alistair, Boukovinas, Ioannis, Moustou, Eleni, Messaritakis, Ippokratis, Chondrozoumaki, Maria, and Karagianni, Michaela

Published
2024
Full Text
View/download PDF

33. eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancers

Author

Waldron, Joseph A., primary, Kanellos, Georgios, additional, Smith, Rachael C. L., additional, Knight, John R. P., additional, Munro, June, additional, Alexandrou, Constantinos, additional, Vlahov, Nikola, additional, Pardo-Fernandez, Luis, additional, Moore, Madeleine, additional, Gillen, Sarah L., additional, Strathdee, Douglas, additional, Stevenson, David, additional, Warrander, Fiona C., additional, Gilroy, Kathryn, additional, Nixon, Colin, additional, Cadden, Barbara, additional, Powley, Ian, additional, Officer-Jones, Leah, additional, Ballantyne, Fiona, additional, Hay, Jennifer, additional, Pennel, Kathryn, additional, Edwards, Joanne, additional, Campbell, Andrew D., additional, Ridgway, Rachel A., additional, Coffelt, Seth B., additional, Norman, Jim, additional, Le Quesne, John, additional, Bushell, Martin, additional, and Sansom, Owen J., additional

Published
2023
Full Text
View/download PDF

35. Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Author

Hanna, Catherine R., O’Cathail, Sean M., Graham, Janet S., Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R., Kelly, Caroline A., Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J., Thomson, Fiona, Adams, Richard A., and Roxburgh, Campbell S. D.

Published
2021
Full Text
View/download PDF

36. Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Author

Hanna, Catherine R., O’Cathail, Sean M., Graham, Janet S., Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R., Kelly, Caroline A., Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J., Thomson, Fiona, Adams, Richard A., and Roxburgh, Campbell S. D.

Published
2021
Full Text
View/download PDF

37. BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

Author

Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, and Leung, Hing Y.

Published
2020
Full Text
View/download PDF

41. Figure S3 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

42. Figure 4 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

43. Figure 5 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

44. Figure 6 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure Legends from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

46. Table S1 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

47. Macrophage reprogramming—rather than depletion—is efficacious in a specific subset of colorectal tumor models

Author

Sansom, Owen, primary, Mohamed, Noha-Ehssan, additional, Graham, Gerry, additional, Lavaud, Xabier Cortes, additional, Amirkhah, Raheleh, additional, Gilroy, Kathryn, additional, Bartolini, Robin, additional, Mulholland, Eoghan, additional, Garg, Abhishek, additional, Pennel, Kathryn, additional, Jackstadt, Rene, additional, Ridgway, Rachel, additional, Nixon, Colin, additional, Hatthakarnku, Phimmada, additional, Campbell, Andrew, additional, Leedham, Simon, additional, Edwards, Joanne, additional, Dunne, Philip, additional, and Barry, Simon, additional

Published
2023
Full Text
View/download PDF

48. Figure 3 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

49. Data from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

50. Figure 1 from β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer

Author

Suzuki, Toshiyasu, primary, Kilbey, Anna, primary, Casa-Rodríguez, Nuria, primary, Lawlor, Amy, primary, Georgakopoulou, Anastasia, primary, Hayman, Hannah, primary, Yin Swe, Kyi Lai, primary, Nordin, Anna, primary, Cantù, Claudio, primary, Vantourout, Pierre, primary, Ridgway, Rachel A., primary, Byrne, Ryan M., primary, Chen, Lei, primary, Verzi, Michael P., primary, Gay, David M., primary, Gil Vázquez, Ester, primary, Belnoue-Davis, Hayley L., primary, Gilroy, Kathryn, primary, Køstner, Anne Helene, primary, Kersten, Christian, primary, Thuwajit, Chanitra, primary, Andersen, Ditte K., primary, Wiesheu, Robert, primary, Jandke, Anett, primary, Blyth, Karen, primary, Roseweir, Antonia K., primary, Leedham, Simon J., primary, Dunne, Philip D., primary, Edwards, Joanne, primary, Hayday, Adrian, primary, Sansom, Owen J., primary, and Coffelt, Seth B., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results